Trial on Safety & Performance of TAXUS Element vs. XIENCE Prime Stent in Treatment of Coronary Lesion in Diabetics

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1830 participants.

Also called NCT03125772

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,830 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03125772
  • CTRI CTRI/2011/06/001830
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
India (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03125772. Randomized; single masking; primary purpose treatment. Start 2011-06 (registry gives no type); primary completion 2015-05 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Trial on Safety & Performance of TAXUS Element vs. XIENCE Prime Stent in Treatment of Coronary Lesion in Diabetics
Acronym
Tuxedo
Condition
Coronary Heart Disease
Intervention (Device)
TAXUS Element™ Paclitaxel-Eluting Stent System
Intervention (Device)
Xience PRIME Everolimus-Eluting Stent System
Lead sponsor
Fortis Escorts Heart Institute (class: other)
Collaborator
Boston Scientific Corporation (class: industry)
Collaborator
Max Neeman Medical International Ltd. (class: not stated)

Record details

Record id
cardio:ct-nct03125772
Content hash
1d3b9f2867be773715b69fef38c0ffd22c14de02c7fdf78cc645b7421442c0b2